Cargando…
A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging
BACKGROUND: Current clinico-pathological American Joint Committee on Cancer (AJCC) staging of primary cutaneous melanoma is limited in its ability to determine clinical outcome, and complementary biomarkers are not available for routine prognostic assessment. We therefore adapted a gene signature, p...
Autores principales: | Brunner, Georg, Heinecke, Achim, Falk, Thomas M, Ertas, Beyhan, Blödorn-Schlicht, Norbert, Schulze, Hans-Joachim, Suter, Ludwig, Atzpodien, Jens, Berking, Carola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649804/ https://www.ncbi.nlm.nih.gov/pubmed/31360859 http://dx.doi.org/10.1093/jncics/pky032 |
Ejemplares similares
-
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007) -
Probiotics synergized with conventional regimen in managing Parkinson’s disease
por: Sun, Hairong, et al.
Publicado: (2022) -
Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity
por: Müller, Kilian, et al.
Publicado: (2023) -
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
por: Franzke, A., et al.
Publicado: (1998) -
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
por: Wessely, Anja, et al.
Publicado: (2021)